Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Kepp

Showing results (261-270 of 364) with videos related to

Pageof 37
Sort By:
Cell Death & Disease|April 4, 2023
Necrocide 1 mediates necrotic cell death and immunogenic response in human cancer cellsJing Zhang, Christina Trojel-Hansen, Jianghuang Wang, et al.
Autophagy|February 25, 2012
Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell deathIsabelle Martins, Mickaël Michaud, Abdul Qader Sukkurwala, et al.
Autophagy|December 11, 2012
Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagyMireia Niso-Santano, Shensi Shen, Sandy Adjemian, et al.
Oncoimmunology|September 14, 2020
Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responsesPeng Liu, Liwei Zhao, Gladys Ferrere, et al.
Cell Death & Disease|February 9, 2018
Evaluation of autophagy inducers in epithelial cells carrying the ΔF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTRShaoyi Zhang, Gautier Stoll, José Manuel Bravo San Pedro, et al.
Cell Death & Disease|August 21, 2020
On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2Allan Sauvat, Fabiola Ciccosanti, Francesca Colavita, et al.
Cell Cycle (Georgetown, Tex.)|May 18, 2012
Preferential killing of p53-deficient cancer cells by reversineMohamed Jemaà, Lorenzo Galluzzi, Oliver Kepp, et al.
Oncoimmunology|July 30, 2016
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapyHeng Yang, Yuting Ma, Guo Chen, et al.
Oncoimmunology|October 25, 2019
Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunityWei Xie, Sabrina Forveille, Kristina Iribarren, et al.
Cytokine & Growth Factor Reviews|June 22, 2013
Crosstalk between ER stress and immunogenic cell deathOliver Kepp, Laurie Menger, Erika Vacchelli, et al.
Pageof 37

Showing results (261-270 of 364) with videos related to

Sort By:
Pageof 37
Cell Death & Disease|April 4, 2023
Necrocide 1 mediates necrotic cell death and immunogenic response in human cancer cellsJing Zhang, Christina Trojel-Hansen, Jianghuang Wang, et al.
Autophagy|February 25, 2012
Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell deathIsabelle Martins, Mickaël Michaud, Abdul Qader Sukkurwala, et al.
Autophagy|December 11, 2012
Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagyMireia Niso-Santano, Shensi Shen, Sandy Adjemian, et al.
Oncoimmunology|September 14, 2020
Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responsesPeng Liu, Liwei Zhao, Gladys Ferrere, et al.
Cell Death & Disease|February 9, 2018
Evaluation of autophagy inducers in epithelial cells carrying the ΔF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTRShaoyi Zhang, Gautier Stoll, José Manuel Bravo San Pedro, et al.
Cell Death & Disease|August 21, 2020
On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2Allan Sauvat, Fabiola Ciccosanti, Francesca Colavita, et al.
Cell Cycle (Georgetown, Tex.)|May 18, 2012
Preferential killing of p53-deficient cancer cells by reversineMohamed Jemaà, Lorenzo Galluzzi, Oliver Kepp, et al.
Oncoimmunology|July 30, 2016
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapyHeng Yang, Yuting Ma, Guo Chen, et al.
Oncoimmunology|October 25, 2019
Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunityWei Xie, Sabrina Forveille, Kristina Iribarren, et al.
Cytokine & Growth Factor Reviews|June 22, 2013
Crosstalk between ER stress and immunogenic cell deathOliver Kepp, Laurie Menger, Erika Vacchelli, et al.
Pageof 37